Our findings indicate that the regulation of tumour cell metabolism by ARRB1 could provide an important area for cancer diagnosis and that preventing its nuclear import could be exploited as a therapeutic tool in limiting prostate cancer progression and metastasis. Here, ARRB1 is linked to prostate cancer.